Kenneth Pienta
Kenneth Pienta
Professor of Urology, Oncology, Pharmacology and Molecular Sciences, Johns Hopkins University
Potvrđena adresa e-pošte na - Početna stranica
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ...
science 310 (5748), 644-648, 2005
Integrative clinical genomics of advanced prostate cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ...
Nature 419 (6907), 624-629, 2002
The mutational landscape of lethal castration-resistant prostate cancer
CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ...
Nature 487 (7406), 239-243, 2012
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer
JS De Bono, HI Scher, RB Montgomery, C Parker, MC Miller, H Tissing, ...
Clinical cancer research 14 (19), 6302-6309, 2008
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ...
Nature 412 (6849), 822-826, 2001
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone
RS Taichman, C Cooper, ET Keller, KJ Pienta, NS Taichman, ...
Cancer research 62 (6), 1832-1837, 2002
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ...
Nature genetics 45 (12), 1446-1451, 2013
Integrative molecular concept modeling of prostate cancer progression
SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ...
Nature genetics 39 (1), 41-51, 2007
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ...
Nature 448 (7153), 595-599, 2007
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ...
Cancer discovery 1 (6), 487-495, 2011
Targeting the tumour stroma to improve cancer therapy
KC Valkenburg, AE De Groot, KJ Pienta
Nature reviews Clinical oncology 15 (6), 366-381, 2018
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression
X Sun, G Cheng, M Hao, J Zheng, X Zhou, J Zhang, RS Taichman, ...
Cancer and Metastasis Reviews 29 (4), 709-722, 2010
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ...
Cancer cell 8 (5), 393-406, 2005
α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ...
Jama 287 (13), 1662-1670, 2002
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...
JAMA oncology 6 (5), 650-659, 2020
Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition
S Shangary, D Qin, D McEachern, M Liu, RS Miller, S Qiu, ...
Proceedings of the National Academy of Sciences 105 (10), 3933-3938, 2008
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow
Y Shiozawa, EA Pedersen, AM Havens, Y Jung, A Mishra, J Joseph, ...
The Journal of clinical investigation 121 (4), 1298-1312, 2011
Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument
PEG Esper, FEI Mo, G Chodak, M Sinner, D Cella, KJ Pienta
Urology 50 (6), 920-928, 1997
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
DR Robinson, YM Wu, S Kalyana-Sundaram, X Cao, RJ Lonigro, ...
Nature genetics 45 (2), 180-185, 2013
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20